AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network (UroCCR) collaborated on a study using a multimodal algorithm to…